APA (7th ed.) Citation

Zhou, H., Wang, Y., Lin, Y., Cai, W., Li, X., & He, X. (2021). Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Zhou, Hong, Yuehui Wang, Yanfang Lin, Wenjie Cai, Xiaofeng Li, and Xiaomeng He. Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study. Frontiers Media S.A, 2021.

MLA (8th ed.) Citation

Zhou, Hong, et al. Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study. Frontiers Media S.A, 2021.